Soergel David 4
4 · MADRIGAL PHARMACEUTICALS, INC. · Filed May 16, 2025
Insider Transaction Report
Form 4
Soergel David
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-05-15+12,839→ 12,839 totalExercise: $291.82Exp: 2035-05-15→ Common Stock (12,839 underlying) - Award
Common Stock
2025-05-15+7,545→ 7,545 total
Footnotes (2)
- [F1]Represents a grant of restricted stock units, which vest as to 25% of the shares on each of May 15, 2026, May 15, 2027, May 15, 2028 and May 15, 2029, provided the Reporting Person continues in service with the Issuer on each such date.
- [F2]The option vests as to 25% of the shares on the first anniversary of the date of grant (May 15, 2026) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date.